Deregulated expression of CD40 ligand in HTLV-I infection: Distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients
- 26 January 2007
- journal article
- Published by Elsevier BV in Virology
- Vol. 362 (1), 99-108
- https://doi.org/10.1016/j.virol.2006.12.020
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?Nature Reviews Cancer, 2006
- Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cellsJournal of Leukocyte Biology, 2003
- The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand ExpressionThe Journal of Experimental Medicine, 2002
- A T Cell-specific Enhancer of the Human CD40 Ligand GenePublished by Elsevier BV ,2002
- Transcriptional Activity of the Distal CD40 Ligand PromoterBiochemical and Biophysical Research Communications, 2000
- IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39Annual Review of Immunology, 1996
- The CD40L Promoter Contains Nuclear Factor of Activated T Cells-binding Motifs Which Require AP-1 Binding for Activation of TranscriptionPublished by Elsevier BV ,1996
- Altered CD40 ligand induction in tolerant T lymphocytesEuropean Journal of Immunology, 1995
- Cyclosporin A inhibits CD40 ligand expression in T lymphocytes.JCI Insight, 1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993